Attovia Therapeutics, Inc. Common Stock (ATTO) — Defensive Interval Ratio

Latest as of June 2026: 2381 days

Attovia Therapeutics, Inc. Common Stock (ATTO) has a Defensive Interval Ratio of 2381 days as of June 2026. Defensive assets of $82.30 Million (cash $-, short-term investments $82.30 Million, receivables $-) cover 2381 days of daily cash needs of $34.56K/day.

Defensive Interval Ratio

2381 days
Days of operational coverage

Defensive Assets

$82.30 Million
Cash + ST Investments + Receivables

Daily Cash Need

$34.56K
Current Liabilities ÷ 365

Current Liabilities

$12.62 Million
USD

Attovia Therapeutics, Inc. Common Stock Defensive Interval Ratio (2024–2025)

This chart shows how Attovia Therapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the ratio stands at 2381 days, meaning defensive assets of $82.30 Million can fund 2381 days of operations without new revenue. For the complete balance sheet picture, see how large is Attovia Therapeutics, Inc. Common Stock's balance sheet.

Annual Defensive Interval Ratio for Attovia Therapeutics, Inc. Common Stock (2024–2025)

The table below presents the year-by-year Defensive Interval Ratio for Attovia Therapeutics, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Attovia Therapeutics, Inc. Common Stock short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2025 3716 days $112.08 Million $30.16K/day $- $112.08 Million ▲ +1888 days
2024 1829 days $38.69 Million $21.16K/day $- $38.69 Million
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)